Can a new pill tame ulcerative colitis?
NCT ID NCT07760831
First seen Aug 12, 2026 · Last updated Aug 13, 2026 · Updated 1 time
Summary
This early-stage trial is testing an experimental oral medication called HRS-7085 in adults with moderate to severe ulcerative colitis, a chronic inflammatory bowel disease. The main goal is to see if the drug is safe and tolerable, and to understand how it moves through the body. Participants will receive either HRS-7085 or a placebo, and researchers will monitor for side effects and measure drug levels in the blood.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- HRS-7085 tablets (an experimental oral drug)
- What this could lead to
- If successful, this could lead to a new oral treatment option for people with moderate to severe ulcerative colitis, potentially helping to control the disease and improve quality of life.
- What could go wrong
- This is an early-phase trial with only 8 participants, so results may not apply to a larger population. The drug may not be effective or may cause unexpected side effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MODERATE TO SEVERE ULCERATIVE COLITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
IMSP Republican Clinical Hospital "Timofei Mosneaga", Clinical Trial Unit ARENSIA EXPLORATORY MEDICINE
Chisinau, Chișinău Municipality, MD-2025, Moldova
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a new injection tame ulcerative colitis?
- New study explores simple tests to replace colonoscopies for colitis patients
- New pill could tame severe gut disease
- New drug shows promise for ulcerative colitis sufferers
- Immune cell therapy takes on IBD: a new hope for tough cases?
- New drug vixarelimab tested for Tough-to-Treat ulcerative colitis